Home All News Page 58

All News

Internet And Biotech Related News

Immuron, IMRN

Corona Craziness Continues. Immuron (IMRN) Gains 10-Fold or 1000%, in 3 Months!

Too bad we don’t trade for a living! We don’t even use real-time quotes, LOL. $2.57 to $27.13, from March 3rd – what...

Reams of Corona Charts. Global Macro Investor.

CLICK TO VIEW amanda@globalmacroinvestor.com Global Macro Investor
Checkpoint Theraputics

11:00 AM Webinar Today, Checkpoint Therapeutics (CKPT) CEO James Olivero.

Virtually meet the CEO of Checkpoint, James Oliviero, on May 28th at 11 am for an update on their two most advanced programs. Checkpoint is evaluating...
Immunomedics, Biotech Stock Review

Immunomedics (IMMU) $33 | Raising Price Potential to $60. American BriVision (ABVC) $3.00 |...

We Are Raising the Price Potential of Immunomedics (IMMU) to $60, Highest on the Street, and Initiating Coverage on Another $3.00 Medical Start-Up American...
Organicell

Corona Craziness Continues. Organicell (BPSR) Gains 10-fold or 1000%, in Six Weeks.

Too bad we don't trade for a living! We don't even use real-time quotes, LOL. $0.02 to $0.27, from Easter - what HOOT-N-HOLLER. LIVE CHART RELATED:...

MRSA: Can Kill Within 24 Hours. Here Are Some Basics.

RESIST THE RESISTANCE: A PRIMER ON ANTIBIOTICS & ANTIBIOTIC RESISTANCE (2013) I was going to write this week about how DEET works, as a follow-up...

MRSA: Methicillin (antibiotic) Resistant Staphylococcus Aureus.

Antibiotic-resistant staph bacteria can lie hidden on your skin for years! Staphylococcus aureus (SA) is a bacterium found in the nose or on the skin...
Organicell

Organicell (BPSR) a Triple Since Easter.

Slowly she turns, step-by-step. $20 million gain in market value. Spurred by FDA Emergency IND's. RELATED: Adding Organicell (BPSR) $0.02 to the Watch List. FDA Approves...

Deficiency of Glutathione as the Most Likely Cause of Serious Manifestations and Death in...

American Chemical Society May 2020. Higher rates of serious illness and death from coronavirus SARS-CoV-2 (COVID-19) infection among older people and those who have comorbidities...

Latest article

Jeffrey Gundlach: Reckoning is Coming.

Jeffrey Edward Gundlach is a businessman, fund manager, and philanthropist. He is the founder of DoubleLine Capital, an investment firm. On 11 November 2020, Gundlach remarked in an interview with...

Who’s the Next Eric Sprott?

Eric Sprott, on Who is the Next Eric Sprott! To say Eric Sprott has left a legendary mark on the world of mining investment would...

Perpetua (PPTA) Raises $300 Million.

Not a bad day in Idaho. $300 million banked! We look at the dip as a buying opportunity, as does John Paulson & Co.,...